Vol. 13, Issue 7 (2024)

Author(s):
Luca Bianchi

Abstract:
This study aims to evaluate the efficacy of bitter gourd (Momordica charantia L.) in reducing oxidative stress in diabetic patients. A total of 50 diabetic patients participated in a randomized, controlled trial. The intervention group received bitter gourd extract, while the control group received a placebo. Biomarkers of oxidative stress, including malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity, were measured before and after the intervention. The results indicated a significant reduction in MDA levels and an increase in SOD activity in the intervention group compared to the control group, suggesting that bitter gourd has potential as a natural antioxidant therapy for diabetic patients.